Randomized phase III U.S./Canadian intergroup trial (SWOG S9704) comparing CHOP ± R for eight cycles to CHOP ± R for six cycles followed by autotransplant for patients with high-intermediate (H-Int) or high IPI grade diffuse aggressive non-Hodgkin lymphoma (NHL)
Stiff, P. J., Unger, J. M., Cook, J., Constine, L. S., Couban, S., Shea, T. C., Winter, J. N., Miller, T. P., Tubbs, R. R., Marcellus, D. C., Friedberg, J. W., Barton, K., Mills, G. M., LeBlanc, M. L., Rimsa, L., Forman, S. J., Fisher, R. I.
Published in Journal of clinical oncology (20.05.2011)
Published in Journal of clinical oncology (20.05.2011)
Get full text
Journal Article